Publications Database

Farmer C. A. et al. (2012)

Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems.

Journal of Autism and Developmental Disorders

June, 4(6), pp. 1037-1044.

Read Abstract (New Window)

Fayyazi A. et al. (2014)

A comparison of risperidone and buspirone for treatment of behavior disorders in children with phenylketonuria.

Iranian Journal of Child Neurology

Fall, 8(4), pp. 33-38.

Read Abstract (New Window) Read Full (New Window)

Fedorow V. , Fombonne E. (2005)

Metabolic side effects of atypical antipsychotics in children: a literature review.

Journal of Psychopharmacology

19(5), pp. 533-550

Read Abstract (New Window)

Fido A. , Al-Saad S. (2008)

Olanzapine in the treatment of behavioral problems associated with autism: an open-label trial in Kuwait.

Medical Principles and Practice

17(5), pp. 415-418

Read Abstract (New Window)

Findling R. L. et al. (2014)

A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.

Journal of Clinical Psychiatry

75(1), pp. 22-30,

Read Abstract (New Window)

Findling R. L. , Maxwell K. , Wiznitzer M. (1997)

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

Psychopharmacology Bulletin

33(1), pp. 155-159

Read Abstract (New Window)

Findling R. L. et al. (2004)

Quetiapine in nine youths with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

14 pp. 287-294

Read Abstract (New Window)

Fisman S. , Steele M. (1996)

Use of risperidone in pervasive developmental disorders: a case series.

Journal of Child and Adolescent Psychopharmacology

Fall, 6(3), pp. 177-190.

Read Abstract (New Window)

Fitzpatrick S. E. et al. (2016)

Aggression in autism spectrum disorder: presentation and treatment options.

Neuropsychiatric Disease and Treatment

2016(12), pp. 1525-1538

Read Abstract (New Window) Read Full (New Window)

British National Formulary (2013)

Antipsychotic drugs.

London: BMJ Publishing Group

Frazier T. W. et al. (2010)

Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder.

Journal of Child and Adolescent Psychopharmacology

20(3), pp, 167-177

Read Abstract (New Window)

Fung L. K. et al. (2012)

A retrospective review of the effectiveness of aripiprazole in the treatment of sensory abnormalities in autism.

Journal of Child and Adolescent Psychopharmacology

22(3), pp. 245-248.

Read Abstract (New Window)

Gagliano A. et al. (2004)

Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.

Journal of Child and Adolescent Psychopharmacology

14(1), pp. 39-47

Read Abstract (New Window)

Gencer O. et al. (2008)

Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder : An open label maintenance study.

European Child and Adolescent Psychiatry

17(4), pp. 217-225

Read Abstract (New Window)

Ghaeli . P. et al. (2014)

Effects of risperidone on core symptoms of autistic disorder based on childhood autism rating scale: an open label study.

Indian Journal of Psychological Medicine

36(1), pp. 66-70.

Read Abstract (New Window) Read Full (New Window)

Ghaleiha A. et al. (2015)

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.

Psychiatry Research

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.

Journal of Psychopharmacology

October, 28(7), pp. 677-685.

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

International Journal of Neuropsycholpharmacology

16(4), pp. 783-789.

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: A double-blind, placebo-controlled, randomized trial.

Pediatric Drugs

15(6), pp. 505-514.

Read Abstract (New Window)

Ghanizadeh A. , Sahraeizadeh A. , Berk M. (2014)

A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.

Child Psychiatry and Human Development

45(2), pp. 185-192.

Read Abstract (New Window)